Suppr超能文献

泛耐药细菌病原体对囊性纤维化患者肺移植术后生存的影响:来自单一大型转诊中心的结果

The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.

作者信息

Dobbin C, Maley M, Harkness J, Benn R, Malouf M, Glanville A, Bye P

机构信息

Department of Respiratory Medicine, Royal Prince Alfred Hospital, Missenden Road, Camperdown NSW 2050, Sydney, Australia.

出版信息

J Hosp Infect. 2004 Apr;56(4):277-82. doi: 10.1016/j.jhin.2004.01.003.

Abstract

Reported actuarial one-year survival for patients with cystic fibrosis (CF) after lung transplant is 55-91%. Infection is the most common cause of early death. Colonization with Burkholderia cepacia complex is associated with reduced survival and international lung transplant referral guidelines support individual unit assessment policies for patients colonized with other pan-resistant bacteria. We examined local data on survival after transplant for CF to determine the impact of colonization with pan-resistant bacteria. A retrospective review of all CF patients from Royal Prince Alfred Hospital (RPAH), Sydney, who underwent lung transplantation at St Vincent's Hospital, Sydney, 1989-2002, was performed. Sixty-five patients were listed for lung transplantation with 54 (male: female=29:25) receiving transplants. Of the 11 patients (17%) who died on the waiting list, six were colonized with pan-resistant Pseudomonas aeruginosa. Thirty of the 54 transplanted patients had at least one pan-resistant organism before transplant. In 28 this included P. aeruginosa. Overall one-year survival was 92% with a median survival of 67 months. Overall survival for the pan-resistant group (N = 30) was not significantly different to survival in those with sensitive organisms (N = 24) (Logrank chi square = 1.6, P = 0.2). Three patients colonized with B. cepacia complex pre-transplant survive at 11, 40 and 60 months post-transplant. Infection contributed to 11 of the 18 post-transplant deaths, with pre-transplant-acquired bacterial pathogens responsible in two cases. Patients continued to acquire multiresistant bacteria post-transplantation. Lung transplant survival at St Vincent's Hospital for CF adults from RPAH compares favourably with international benchmarks. Importantly, colonization with pan-resistant bacteria pre-transplant did not appear to adversely affect survival post-transplant.

摘要

据报告,囊性纤维化(CF)患者肺移植后的精算一年生存率为55%-91%。感染是早期死亡的最常见原因。洋葱伯克霍尔德菌复合体定植与生存率降低相关,国际肺移植转诊指南支持对其他泛耐药菌定植患者的个体化单位评估政策。我们研究了CF患者移植后生存的本地数据,以确定泛耐药菌定植的影响。对1989年至2002年在悉尼圣文森特医院接受肺移植的悉尼皇家阿尔弗雷德王子医院(RPAH)的所有CF患者进行了回顾性研究。65例患者被列入肺移植名单,54例(男∶女=29∶25)接受了移植。在等待名单上死亡的11例患者(17%)中,6例定植有泛耐药铜绿假单胞菌。54例移植患者中有30例在移植前至少有一种泛耐药菌。其中28例包括铜绿假单胞菌。总体一年生存率为92%,中位生存期为67个月。泛耐药组(N=30)的总体生存率与敏感菌组(N=24)的生存率无显著差异(对数秩卡方=1.6,P=0.2)。3例移植前定植有洋葱伯克霍尔德菌复合体的患者在移植后11个月、40个月和60个月存活。感染导致18例移植后死亡中的11例,2例由移植前获得的细菌病原体引起。患者移植后继续获得多重耐药菌。悉尼圣文森特医院RPAH成年CF患者的肺移植生存率与国际基准相比具有优势。重要的是,移植前泛耐药菌定植似乎并未对移植后生存产生不利影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验